for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Market News

BRIEF-Halozyme Reports Q1 Loss Per Share $0.19

May 10 (Reuters) - Halozyme Therapeutics Inc:

* HALOZYME REPORTS FIRST QUARTER 2018 RESULTS

* Q1 LOSS PER SHARE $0.19

* Q1 REVENUE $30.9 MILLION VERSUS I/B/E/S VIEW $31.8 MILLION

* Q1 EARNINGS PER SHARE VIEW $-0.22 -- THOMSON REUTERS I/B/E/S

* SEES FY 2018 NET REVENUE OF $115 MILLION TO $125 MILLION, INCLUDING 25 TO 30 PERCENT ROYALTY GROWTH Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up